SYRE - Spyre Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$119.89
DETAILS
HIGH:
$130.00
LOW:
$107.00
MEDIAN:
$120.00
CONSENSUS:
$119.89
UPSIDE:
50.05%
AlphaVal
Deterministic, archetype-aware fair value
AlphaVal Unavailable
AlphaVal: SYRE has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.